Benjamin Martin is a partner in the Health Care and Life Sciences Practice of Epstein Becker Green in Washington, DC, where he practices in the Pharmaceutical Industry Health Regulatory Group. Mr. Martin provides regulatory counseling and litigation support on a wide range of issues affecting pharmaceutical and medical device manufacturers, and other entities in those products’ supply chains, including:
- Approval, manufacture, promotion, distribution, and import/export of pharmaceuticals and medical devices;
- Coding, coverage and payment of pharmaceuticals and medical devices by health care insurers, including governmental programs, private plans, and managed care organizations;
- Calculation and reporting of prices of pharmaceuticals utilized by governmental health care insurance and procurement programs;
Fraud and abuse issues associated with pharmaceutical and medical device marketing practices; and
- All phases of government inquiries and investigations.
Before joining EBG, Mr. Martin was an associate in the pharmaceutical and medical device practice group of a large Washington, DC law firm. Prior to that, he was a law clerk for the Honorable Phyllis A. Kravitch, U.S. Court of Appeals for the Eleventh Circuit.
Ben graduated summa cum laude with a B.S. from the University of South Carolina in 1995. He received a J.D. from the University of Virginia School of Law in 1999, where he was a member of Order of the Coif and the Virginia Law Review. He has been admitted to the Bar in Washington, DC and Maryland. He has court admission to the U.S. Courts of Appeals for the Fourth and Eleventh Circuits, and is a member of the American Bar Association, the American Health Lawyers Association, and the Food & Drug Law Institute.